The corporate dealmakers we talk to tend to have short, well-defined lists of things they like to use investment bankers for. See, for example, our post on the fact that Oracle Corp. accomplished its
big, hostile takeover of BEA Systems Inc. without i-bankers, and also this very funny column by our adviser Josh King on the
uses and abuses of i-bankers.
Now, at a time when i-bankers could probably use some standing-up for, here come the folks over at the In Vivo blog with a slightly different view. In a recent
survey of biz dev execs in medical devices, pharma and biotech, between a quarter and a third of 109 respondents rated bankers either "very helpful" or "invaluable" in bringing them M&A opportunities, structuring deals or raising money. -
Kenneth Klee
Join Corporate Dealmaker's LinkedIn forum
Juergen Lasowski
And the winners are...
